| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/03/2013 | WO2012145523A3 Aav mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity |
| 01/03/2013 | WO2012141504A3 Brg-1-derived bromodomain, and use thereof |
| 01/03/2013 | WO2012138708A8 Mhc engagement and clip modulation for the treatment of disease |
| 01/03/2013 | WO2012135695A3 Modulation of cellular migration |
| 01/03/2013 | WO2012134240A3 Lyophilized preparation of botulinum toxin |
| 01/03/2013 | WO2012134234A3 Use of hades as a negative modulator of akt |
| 01/03/2013 | WO2012129394A3 Methods and compositions for the treatment of cancer |
| 01/03/2013 | WO2012128521A3 Pharmaceutical composition for treating aging-associated diseases, containing progerin expression inhibitor as active ingredient, and screening method of said progerin expression inhibitor |
| 01/03/2013 | WO2012128502A9 Composition for promoting vasculogenesis comprising pauf |
| 01/03/2013 | WO2012118863A9 Therapies that target autoimmunity for treating glaucoma and optic neuropathy |
| 01/03/2013 | WO2012101599A3 Glycogen synthase kinase-3 inhibitors |
| 01/03/2013 | WO2012098546A3 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof |
| 01/03/2013 | WO2012093258A3 Irf5- related treatment and screening |
| 01/03/2013 | WO2012087913A3 Peptide reagents and methods for detection of colon dysplasia |
| 01/03/2013 | WO2012075173A3 Compositions and method for deimmunization of proteins |
| 01/03/2013 | WO2011163648A8 Cns delivery of therapeutic agents |
| 01/03/2013 | WO2009095796A3 Tapasin augmentation for enhanced immune response |
| 01/03/2013 | US20130007926 Administration of plant expressed oral tolerance agents |
| 01/03/2013 | US20130006351 Polymer coatings containing drug powder of controlled morphology |
| 01/03/2013 | US20130005668 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
| 01/03/2013 | US20130005667 Heterologous expression of neisserial proteins |
| 01/03/2013 | US20130005666 Reporter system for high throughput screening of compounds and uses thereof |
| 01/03/2013 | US20130005665 Macrogol 15 hydroxystearate formulations |
| 01/03/2013 | US20130005664 Therapeutic agents comprising elastic peptides |
| 01/03/2013 | US20130005663 Smac peptidometics useful as iap inhibitors |
| 01/03/2013 | US20130005662 Methods of Treating Depression and Other Related Diseases |
| 01/03/2013 | US20130005661 Pharmaceutical compositions |
| 01/03/2013 | US20130005660 Plasma Activation of Biological Materials for Surface Modification |
| 01/03/2013 | US20130005659 Il-17 binding compounds and medical uses thereof |
| 01/03/2013 | US20130005658 Micro-rna regulation in ischemia and ischemia-reperfusion injury |
| 01/03/2013 | US20130005657 SYNERGISTIC THERAPEUTIC USE OF PROTHROMBIN COMPLEX CONCENTRATES WITH FVlll CONCENTRATES |
| 01/03/2013 | US20130005656 Modified Factor VIII |
| 01/03/2013 | US20130005655 Combination therapy using low-dose doxepin for the improvement of sleep |
| 01/03/2013 | US20130005654 Therapeutic agent for accelerating recovery of animal under medical treatment |
| 01/03/2013 | US20130005653 Polypeptides |
| 01/03/2013 | US20130005652 Methods for administering long-lasting hypoglycemic agents |
| 01/03/2013 | US20130005651 Death associated protein 1 variants and use thereof for modulating autophagy |
| 01/03/2013 | US20130005650 Methods and compositions for treating diseases associated with pathogenic proteins |
| 01/03/2013 | US20130005649 Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| 01/03/2013 | US20130005648 Peptide compositions and methods for inhibiting herpesvirus infection |
| 01/03/2013 | US20130005647 Mutant nisin ser 29 derivatives and the use thereof |
| 01/03/2013 | US20130005646 Polypeptides |
| 01/03/2013 | US20130005645 Apoe peptide dimers and uses thereof |
| 01/03/2013 | US20130005644 Cyclic agonists and antagonists of c5a receptors and g protein-coupled receptors |
| 01/03/2013 | US20130005643 Method for preparing nano-particles |
| 01/03/2013 | US20130005642 Methods for recovering peptides/amino acids and oil/fat from one or more protein-containing raw materials, and products produced by the methods |
| 01/03/2013 | US20130004601 Appetite regulating dietary supplement |
| 01/03/2013 | US20130004577 Coated tablet |
| 01/03/2013 | US20130004565 Proteolytic enzyme formulations |
| 01/03/2013 | US20130004564 Antimicrobial peptides |
| 01/03/2013 | US20130004559 Flat self-curling permeable sheet membrane |
| 01/03/2013 | US20130004543 Fibronectin: growth factor chimeras |
| 01/03/2013 | US20130004542 Composition |
| 01/03/2013 | US20130004541 Polymer nanofiber scaffold for a heparin / fibrin based growth factor delivery system |
| 01/03/2013 | US20130004524 Conjugated Proteins |
| 01/03/2013 | US20130004522 Phototriggered nanoparticles for cell and tissue targeting |
| 01/03/2013 | US20130004515 Methods for treating reperfusion injuries |
| 01/03/2013 | US20130004512 Nucleic acid molecules encoding bank1 splice variants |
| 01/03/2013 | US20130004507 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 01/03/2013 | US20130004502 Influenza targets |
| 01/03/2013 | US20130004492 Fgfr extracellular domain acidic region muteins |
| 01/03/2013 | US20130004490 Delivery of transthyretin across the blood-brain barrier as a treatment for alzheimer's disease |
| 01/03/2013 | US20130004488 Anti-cancer agent delivery vehicles capable of improved loading |
| 01/03/2013 | US20130004482 Methods of Treating Breast Cancer with Anthracycline Therapy |
| 01/03/2013 | US20130004478 Procoagulant Peptides and Their Derivatives and Uses Therefor |
| 01/03/2013 | US20130004477 Methods for Treating Inflammation and Oxidative Stress Related Diseases |
| 01/03/2013 | US20130004476 Chimeric Polypeptides and Their Use in Bacterial Decolonization |
| 01/03/2013 | US20130004461 Subfamily e simian adenoviruses a1321, a1325, a1295, a1309, a1316 and a1322 and uses thereof |
| 01/03/2013 | US20130004460 Silylated biomolecules |
| 01/03/2013 | US20130004459 Methods, pharmaceutical compositions and kits for use in the treatment of adult t-cell leukemia/lymphoma |
| 01/03/2013 | US20130004458 Small Molecule Inhibitors of Retroviral Assembly and Maturation |
| 01/03/2013 | US20130004457 Hepatitis C Virus Inhibitors |
| 01/03/2013 | US20130004444 Composition containing at least one c7 sugar for alopecia treatment, cosmetic treatment of hair and nails, and care of hair, eyelashes, or nails |
| 01/03/2013 | US20130004436 Compositions and Methods of Treating and Preventing Lung Cancer and Lymphangioleiomyomatosis |
| 01/03/2013 | US20130004431 Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof |
| 01/03/2013 | US20130004429 Use of a neurofilament peptide for the treatment of glioma |
| 01/03/2013 | US20130004424 Methods for determining agents targeting mena isoforms and uses thereof for diagnosis and treatment of metastatic tumors |
| 01/03/2013 | US20130004415 Joint-Homing Peptides and Uses Thereof |
| 01/03/2013 | CA2840617A1 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 01/03/2013 | CA2840577A1 Soluble integrin .alpha.4 mutant |
| 01/03/2013 | CA2840568A1 Compositions, uses, and preparation of platelet lysates |
| 01/03/2013 | CA2840290A1 Procoagulant peptides and their derivatives and uses therefor |
| 01/03/2013 | CA2839709A1 A chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity |
| 01/03/2013 | CA2839622A1 Wap domain fusion polypeptides and methods of use thereof |
| 01/03/2013 | CA2839619A1 Serpin fusion polypeptides and methods of use thereof |
| 01/03/2013 | CA2839410A1 Exendin-4 analogue pegylated with polyethylene glycol or derivative thereof, preparation method thereof, and pharmaceutical composition for prevention or treatment of diabetes containing the same as active ingredient |
| 01/03/2013 | CA2836855A1 Polypeptides and uses thereof for treatment of autoimmune disorders and infection |
| 01/03/2013 | CA2831154A1 Use of pertussis toxin as a therapeutic agent |
| 01/02/2013 | EP2540737A1 Use of multivalent synthetic ligands of surface nucleolin for the treatment of inflammation |
| 01/02/2013 | EP2540736A2 Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity |
| 01/02/2013 | EP2540735A2 Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity |
| 01/02/2013 | EP2540703A1 Guanylhydrazone salts, compositions, processes of making and methods of using |
| 01/02/2013 | EP2540350A1 Combinations of a macrocyclic quinoxaline compound which is an HCV NS3 protease inhibitors with other HCV agents |
| 01/02/2013 | EP2540349A1 Pharmaceutical compositions comprising a macrocyclic quinoxaline compound which is an HCV NS3 protease inhibitor |
| 01/02/2013 | EP2540316A1 Composition for controlling weight gain and food product containing the same |
| 01/02/2013 | EP2540310A1 Methods of treating cartilage defects using a soluble morphogenic protein complex |
| 01/02/2013 | EP2540309A2 Tissue protective peptides and uses thereof |
| 01/02/2013 | EP2540308A1 Therapeutic agent for eating disorders |
| 01/02/2013 | EP2540307A1 Antibacterial auxiliary agent comprising kombu extract as active ingredient, antibacterial composition, and food or beverage |
| 01/02/2013 | EP2540302A1 Methods and pharmaceutical compositions for healing wounds |